www.excelsiorsolutions.com
Open in
urlscan Pro
209.240.94.12
Public Scan
Submitted URL: http://excelsiorsolutions.com/
Effective URL: http://www.excelsiorsolutions.com/
Submission: On March 07 via manual from US — Scanned from DE
Effective URL: http://www.excelsiorsolutions.com/
Submission: On March 07 via manual from US — Scanned from DE
Form analysis
2 forms found in the DOMGET http://www.excelsiorsolutions.com/
<form aria-label="Search this website" role="search" method="get" class="searchform" action="http://www.excelsiorsolutions.com/">
<input aria-label="Insert search query" type="search" id="ocean-search-form-1" class="field" autocomplete="off" placeholder="Search" name="s">
</form>
GET http://www.excelsiorsolutions.com/
<form aria-label="Search this website" method="get" action="http://www.excelsiorsolutions.com/" class="mobile-searchform">
<input aria-label="Insert search query" value="" class="field" id="ocean-mobile-search-2" type="search" name="s" autocomplete="off" placeholder="Search">
<button aria-label="Submit search" type="submit" class="searchform-submit">
<i class=" icon-magnifier" aria-hidden="true" role="img"></i> </button>
</form>
Text Content
Skip to content * Home * Services * Audit Services * PBM Consulting * Specialty Drug Management * Medicare & Medicaid * Pharmacy Audit Services * About Us * Leadership * Insights & Publications * Case Studies * Newsletters * Industry News * Contact Us * Toggle website search Menu Close * Home * Services * Audit Services * PBM Consulting * Specialty Drug Management * Medicare & Medicaid * Pharmacy Audit Services * About Us * Leadership * Insights & Publications * Case Studies * Newsletters * Industry News * Contact Us * Toggle website search THE EXCELSIOR SOLUTIONS DIFFERENCE PBM CONSULTING Substantially reducing pharmacy benefit costs without sacrificing plan quality. SPECIALTY DRUG MANAGEMENT Managing one of the largest hidden costs of medical care. MEDICARE & MEDICAID Navigating a complex marketplace. ABOUT US Your cutting-edge expert with the resources to manage your pharmacy program effectively, contain cost, and be accountable for the results. We are the next generation; we are the solution. Read More INSIGHTS & PUBLICATIONS NEWSLETTERS Q1 2023 EXCELSIOR NEWSLETTER Drug Trends to Watch, Actions to Consider by Robert Kordella, RPh, MBASenior Vice President and Chief Clinical Officer DIABETES Rising prescription costs related to the Q3 2022 EXCELSIOR NEWSLETTER Excelsior’s Opinion on So-Called “Vision Enhancement Products” by Robert Kordella, RPh, MBA, Chief Clinical Officer Three products have come to market recently that are being Q2 2022 EXCELSIOR NEWSLETTER Humira Savings on the Horizon? by Robert Kordella, RPh, MBA, Chief Clinical Officer In 2021, Humira (adalimumab) amassed $21 billion in sales in the U.S. CASE STUDIES PHARMACY RENEGOTIATION THROUGH EXCELSIOR SOLUTIONS Pharmacy renegotiation through Excelsior Solutions Annual Pharmacy Savings of $6.3M (23% USING DATA TO IDENTIFY FRAUDULENT CLAIMS Using Data to Identify Fraudulent Claims Pharmacy Reimbursement of $26,000 Challenge OPIOID CASE STUDY Opioid Case Study Annual Savings of $192,000 Challenge Member filling pain INDUSTRY NEWS BIOSIMILARS: IS THE PROMISE OF SAVING BEING REALIZED BY HEALTH PLANS With increasing specialty drug costs, pharmacy benefit managers,health plans and industry experts often tout the use of biosimilarsas a strategy to lower cost. In 2013, HUMALOG LISPRO NEWS As you may recall, back in March of this year, Eli Lilly announced that they would begin to manufacture and sell an authorized generic version GENERIC ADVAIR DISKUS APPROVED The news that the FDA approved the first A-rated (meaning that pharmacists may freely substitute it without physician approval) generic form of Advair Diskus on ICER UPDATE 10.04.22 Hello everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. ICER released a Final Evidence Report assessing the comparative clinical effectiveness and value ICER UPDATE 01.27.22 Hello everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. ICER has published its latest report on Unsupported Price Increases (UPI) of prescription ICER UPDATE 01.22.21 Hello, everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER has published its latest report on SERVICES * PBM Consulting * Specialty Drug Management * Medicare & Medicaid COMPANY * About Us * Leadership * Insights & Publications * Contact Us * Privacy Policy EXCELSIOR SOLUTIONS 7650 Edinborough Way Suite 100 Edina, MN 55435 (952) 657-5457 © Copyright 2019 Excelsior Solutions • Privacy Policy • All Rights Reserved